Quantitative Value Technologies’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$373K Sell
5,582
-353
-6% -$23K 0.61% 55
2021
Q1
$375K Buy
+5,935
New +$369K 0.81% 35

Other funds holding BMY

Quantitative Value Technologies's BMY Position: Q2 2021 in Review

Quantitative Value Technologies reduced its Bristol-Myers Squibb (BMY) stake by 5.9% in Q2 2021, selling an estimated $23K and leaving 5,582 shares worth $373K. The position accounts for 0.61% of the portfolio, ranked #55.

Quantitative Value Technologies first reported a position in BMY in Q1 2021 and has held it in 2 quarters since. The position peaked at $375K in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Quantitative Value Technologies held 5,582 shares of Bristol-Myers Squibb worth $373K as of Q2 2021.
  • Quantitative Value Technologies sold 353 Bristol-Myers Squibb shares in Q2 2021, an estimated $23K.
  • Bristol-Myers Squibb made up 0.61% of Quantitative Value Technologies's portfolio in Q2 2021, its #55 holding.
  • Quantitative Value Technologies first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 2 quarters since.
  • Quantitative Value Technologies's Bristol-Myers Squibb position peaked at $375K in Q1 2021.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Quantitative Value Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.